A protein called GRP78 could be a universal therapeutic target for treating human diseases like brain cancer, Ebola, Influenza, Hepatitis and superbug bacteria such as Methicillin-resistant Staphylococcus epidermidis and Methicillin-resistant Staphylococcus aureus, according to a study.